Wordt geladen...
Targeting CD73 in the tumor microenvironment with MEDI9447
MEDI9447 is a human monoclonal antibody that is specific for the ectoenzyme CD73 and currently undergoing Phase I clinical trials. Here we show that MEDI9447 is a potent inhibitor of CD73 ectonucleotidase activity, with wide ranging immune regulatory consequences. MEDI9447 results in relief from ade...
Bewaard in:
Gepubliceerd in: | Oncoimmunology |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Taylor & Francis
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5007986/ https://ncbi.nlm.nih.gov/pubmed/27622077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1208875 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|